Tc compositions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9694092
APP PUB NO 20090311178A1
SERIAL NO

11721064

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to stabilised 99mTc radiopharmaceutical compositions of the ligand tetrofosmin, which include an ascorbic acid or ascorbate radioprotectant, in the absence of an antimicrobial preservative. The invention also provides lyophilised kits suitable for the bulk preparation of multiple unit patient doses of 99mTc-tetrofosmin metal complexes. Also disclosed are unit doses of 99mTc-tetrofosmin, together with processes for preparing such unit doses from the lyophilised bulk vial.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GE HEALTHCARE LIMITEDAMERSHAM PLACE LITTLE CHALFONT BUCKINGHAMSHIRE HP8 4SP

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hjelstuen, Ole Kristian Olso, NO 5 21
Martinussen, Grethe Karin Olso, NO 1 5
Stensrud, Gry Olso, NO 6 35

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 4, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 4, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00